Arch Therapeutics, Inc. (ARTH)
USD 0.23
(31.81%)
USD 0.23
(31.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 75.72 Thousand | 15.65 Thousand | 11.56 Thousand | - | - | - |
| Cost of Revenue | 78.16 Thousand | 51.48 Thousand | 26.28 Thousand | 6926.00 | 8238.00 | 5342.00 |
| Gross Profit | -2439.00 | -35.83 Thousand | -14.71 Thousand | -6926.00 | -8238.00 | -5342.00 |
| Operating Expenses | 5.04 Million | 5.67 Million | 6.36 Million | 5.37 Million | 6.37 Million | 7.44 Million |
| Selling, General and Administrative Expenses | 4.37 Million | 4.51 Million | 5 Million | 3.75 Million | 3.97 Million | 4.56 Million |
| Research and Development Expenses | 670.88 Thousand | 1.15 Million | 1.35 Million | 1.61 Million | 2.39 Million | 2.88 Million |
| Other Expenses | - | - | 178.22 Thousand | - | - | - |
| Cost and Expenses | 5.12 Million | 5.72 Million | 6.38 Million | 5.37 Million | 6.37 Million | 7.44 Million |
| Operating Income | -5.04 Million | -5.7 Million | -6.37 Million | -5.37 Million | -6.37 Million | -7.44 Million |
| Interest Expense | 3.09 Million | 567.04 Thousand | 150.53 Thousand | 18 Thousand | - | - |
| Income Tax Expense | - | -1 Million | 328.76 Thousand | -679.27 Thousand | -1.82 Million | 2.63 Million |
| Earnings before Tax | -6.98 Million | -5.27 Million | -6.24 Million | -4.69 Million | -4.54 Million | -4.81 Million |
| Net Income | -6.98 Million | -4.27 Million | -6.56 Million | -4.01 Million | -2.72 Million | -4.81 Million |
| Earnings Per Share Basic | -2.27 | -3.56 | -5.97 | -4.27 | -3.27 | -6.30 |
| Earnings Per Share Diluted | -2.27 | -3.56 | -5.97 | -4.27 | -3.27 | -6.30 |
| Weighted Average Shares Outstanding | 3.07 Million | 1.19 Million | 1.1 Million | 940.25 Thousand | 831.69 Thousand | 763.56 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.07 Million | 1.19 Million | 1.1 Million | 940.25 Thousand | 831.69 Thousand | 763.56 Thousand |
| Gross Margin | -0.03 | -2.29 | -1.27 | - | - | - |
| EBIT Margin | -51.30 | -364.53 | -535.78 | - | - | - |
| Profit Margin | -92.21 | -273.18 | -568.03 | - | - | - |
| EBITDA | -3.88 Million | -4.7 Million | -6.08 Million | -5.34 Million | -6.36 Million | -7.44 Million |
| Earnings Before Tax Margin | -66.62 | -364.73 | -551.42 | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 30.91 Thousand | 31.86 Thousand | 45.86 Thousand | 75.72 Thousand | 39.51 Thousand | 13.29 Thousand |
| Cost of Revenue | 21.07 Thousand | 21.55 Thousand | 23.6 Thousand | 78.16 Thousand | 23.28 Thousand | 18.52 Thousand |
| Gross Profit | 9834.00 | 10.31 Thousand | 22.26 Thousand | -2439.00 | 16.23 Thousand | -5236.00 |
| Operating Expenses | 1.03 Million | 887.05 Thousand | 1.51 Million | 5.04 Million | 1.34 Million | 1 Million |
| Selling, General and Administrative Expenses | 875.62 Thousand | 683.18 Thousand | 1.31 Million | - | 1.14 Million | 870.05 Thousand |
| Research and Development Expenses | 155.68 Thousand | 203.86 Thousand | 205.58 Thousand | - | 199.74 Thousand | 139.04 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.05 Million | 908.6 Thousand | 1.54 Million | 5.12 Million | 1.36 Million | 1.02 Million |
| Operating Income | -1.02 Million | -876.74 Thousand | -1.49 Million | -5.04 Million | -1.32 Million | -1.01 Million |
| Interest Expense | 671.92 Thousand | 592.39 Thousand | 1.18 Million | 3.09 Million | 1.12 Million | 808.77 Thousand |
| Income Tax Expense | 5.00 | 1.00 | -1.49 Million | 4.00 | -43.16 Thousand | 39.85 Thousand |
| Earnings before Tax | -5.65 Million | -1.46 Million | -2.68 Million | -6.98 Million | -2.45 Million | -1.82 Million |
| Net Income | -5.65 Million | -1.46 Million | -2.68 Million | -6.98 Million | -2.45 Million | -1.82 Million |
| Earnings Per Share Basic | -1.27 | -0.33 | -0.57 | - | -0.52 | -1.42 |
| Earnings Per Share Diluted | -1.27 | -0.33 | -0.57 | - | -0.52 | -1.42 |
| Weighted Average Shares Outstanding | 4.44 Million | 4.49 Million | 4.7 Million | 3.07 Million | 4.68 Million | 1.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.44 Million | 4.49 Million | 4.7 Million | 3.07 Million | 4.68 Million | 1.27 Million |
| Gross Margin | 0.32 | 0.32 | 0.49 | -0.03 | 0.41 | -0.39 |
| EBIT Margin | -33.03 | -27.50 | -32.57 | - | -33.61 | -76.29 |
| Profit Margin | -182.92 | -46.10 | -58.47 | -92.21 | -62.18 | -137.15 |
| EBITDA | -1.02 Million | -876.18 Thousand | -1.49 Million | - | -1.32 Million | -1.01 Million |
| Earnings Before Tax Margin | -33.04 | -27.51 | -32.59 | -66.62 | -33.63 | -76.31 |
DDOG
CXB
NACLIND
THOMASCOOK
BNNNF
2380